Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07456189) titled 'The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating' on Feb. 27.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Condition:
HSCT
Hematologic Cancer
Intervention:
Radiation: Stereotactic body radiotherapy (SBRT)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollm...